Cargando…

Esophagitis after administration of the 1273-RNAm SARS-CoV-2 vaccine()

Detalles Bibliográficos
Autores principales:	Velilla Moliner, Joaquín, Garcia Palacio, Jessica, Barberán Bernardos, Alba
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier España, S.L.U. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250884/ https://www.ncbi.nlm.nih.gov/pubmed/35813403 http://dx.doi.org/10.1016/j.medcle.2022.07.001

Ejemplares similares

Esofagitis aguda tras la administración de vacuna ARNm-1273 contra el SARS-COV-2
por: Velilla Moliner, Joaquín, et al.
Publicado: (2022)

Parsonage Turner Syndrome Following Vaccination With mRNA-1273 SARS-CoV-2 Vaccine
por: Bernheimer, James H., et al.
Publicado: (2022)

Small-Fiber Neuropathy After Vaccination With mRNA-1273 SARS-CoV-2 Vaccine
por: Bernheimer, James H., et al.
Publicado: (2023)

Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine
por: Holzworth, Amy, et al.
Publicado: (2021)

Humoral response of the mRNA-1273 SARS-CoV-2 vaccine in peritoneal dialysis patients
por: Rodríguez-Espinosa, Diana, et al.
Publicado: (2021)

Esophagitis and SARS-CoV-2 vaccine
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Esophagitis and SARS-CoV-2 vaccine: Correspondence
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Acute myopericarditis after administration of mRNA vaccines against the SARS-CoV-2 virus()
por: Gómez Martín, Alba María, et al.
Publicado: (2022)

Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine
por: Benotmane, Ilies, et al.
Publicado: (2021)

Vasculitic flare in a patient with anti-myelin-associated glycoprotein (MAG) antibody following mRNA-1273 SARS-CoV-2 vaccine
por: Briani, Chiara, et al.
Publicado: (2022)

[Translated article] Pleuropericardial Effusion and Systemic Inflammatory Syndrome Secondary to the Administration of the mRNA-1273 Vaccine for SARS-CoV-2
por: Boira, Ignacio, et al.
Publicado: (2022)

Herpes zoster reactivation after mRNA-1273 (Moderna) SARS-CoV-2 vaccination
por: Channa, Leelakrishna, et al.
Publicado: (2021)

De novo vasculitis after mRNA-1273 (Moderna) vaccination
por: Anderegg, Manuel A., et al.
Publicado: (2021)

Comparison of BNT162b2 (Pfizer–BioNtech) and mRNA-1273 (Moderna) SARS-CoV-2 mRNA vaccine immunogenicity in dialysis patients
por: Kaiser, Robert A., et al.
Publicado: (2021)

Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination: Author's response
por: Pereson, Matías J., et al.
Publicado: (2022)

Radiation recall phenomenon after administration of the mRNA-1273 SARS-CoV-2 vaccine
por: Ishikawa, Yojiro, et al.
Publicado: (2022)

Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers
por: Tré-Hardy, Marie, et al.
Publicado: (2021)

Re: Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Vaccine-induced immune thrombocytopenia and thrombosis after mRNA-1273 booster vaccination
por: Langerak, T., et al.
Publicado: (2022)

Guillain–Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report
por: Masuccio, Fabio Giuseppe, et al.
Publicado: (2021)

Livedo reticularis on bilateral knees after the third dose of messenger RNA-1273 SARS-CoV-2 vaccine
por: Mintz, Michelle Amy, et al.
Publicado: (2022)

Motor and non-motor symptom improvement after mRNA-1273 vaccine in a Parkinson’s disease patient
por: Contaldi, Elena, et al.
Publicado: (2021)

Association Between Fever and Antibody Titer Trends After a Third Dose of the mRNA-1273 Vaccine
por: Matsumoto, Naomi, et al.
Publicado: (2022)

Covid-19 vaccine management (Comirnaty and mrna-1273 Moderna) in a teaching hospital in Italy: a short report on the vaccination campaign
por: Papini, Francesca, et al.
Publicado: (2021)

Autoimmune hepatitis following SARS-CoV-2 vaccine: May not be a casuality
por: Rocco, Alba, et al.
Publicado: (2021)

Association between RNAm-Based COVID-19 Vaccines and Permanency of Menstrual Cycle Alterations in Spanish Women: A Cross-Sectional Study
por: Mínguez-Esteban, Isabel, et al.
Publicado: (2022)

Humoral and cellular immune responses to the mRNA-1273 SARS-CoV-2 vaccine booster in patients on maintenance dialysis
por: Karakizlis, Hristos, et al.
Publicado: (2022)

Another case of autoimmune hepatitis after SARS-CoV-2 vaccination – still casualty?
por: Londoño, Maria-Carlota, et al.
Publicado: (2021)

HCV detection is possible during SARS CoV-2 testing; and throughout COVID-19 vaccination?
por: Crespo, Javier, et al.
Publicado: (2021)

Incidence of SARS-CoV-2 Infection in Health Care Workers After a Single Dose of mRNA-1273 Vaccine
por: Gupta, Kalpana, et al.
Publicado: (2021)

Durability of Protection Against Symptomatic COVID-19 Among Participants of the mRNA-1273 SARS-CoV-2 Vaccine Trial
por: Lin, Dan-Yu, et al.
Publicado: (2022)

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
por: Baden, Lindsey R., et al.
Publicado: (2020)

Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents
por: Ali, Kashif, et al.
Publicado: (2021)

Seroconversion panels demonstrate anti-SARS-CoV-2 antibody development after administration of the mRNA-1273 vaccine
por: Belda, Francisco, et al.
Publicado: (2022)

SARS-CoV-2 vaccination and metabolic radionuclide therapy: Document of the SEMNIM Endocrinology Working Group()
por: Negre Busó, Montserrat, et al.
Publicado: (2021)

Distinct glomerular disease association after vaccination with BNT162b2 and mRNA-1273: a VigiBase analysis
por: Kronbichler, Andreas, et al.
Publicado: (2022)

SARS-CoV-2 antibody response eight months after vaccination with mRNA vaccines. Influence of prior SARS-CoV-2 exposure
por: García-Cruces-Méndez, Jesús Fernando, et al.
Publicado: (2022)

Worsening of immune thrombocytopenic purpura in SARS-CoV-2 vaccinated patients()
por: García Ramírez, Patricia, et al.
Publicado: (2022)

Leukocytoclastic Vasculitis and SARS-COV-2 Vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2022)

Hashimoto encephalopathy after vaccination against SARS-CoV-2
por: Viscasillas Sancho, M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9tlijuidgmom7o1ndmndt92f4j